IgMAT
IgMAT annotates immunoglobulin (antibody) sequences from high-throughput sequencing datasets to map framework (FR) and complementarity-determining regions (CDRs) across diverse species.
Key Features:
- Species-Agnostic Annotation: Annotates antibody sequences from diverse species and accepts user-defined datasets to represent species-specific structural characteristics.
- Reduced Amino Acid Alphabet and HMM Alignments: Uses a reduced amino acid alphabet and combines multiple Hidden Markov Model (HMM) alignments into a single consensus model to improve annotation accuracy across species.
- Customizability: Allows users to add custom antibody sequence datasets for annotation of non-standard or underrepresented species.
- Output Formats: Generates output formats including BED files that contain coordinates for Framework (FR) and Complementarity-Determining Regions (CDR).
Scientific Applications:
- Immunogenetics: Supports immunogenetics studies requiring precise annotation of antibody regions.
- Immune Repertoire Profiling: Enables mapping of changes in polyclonal immune repertoires from high-throughput sequencing, including responses to disease and vaccination.
- Cross-Species Antibody Research: Facilitates analysis of antibody repertoires from non-model species by allowing custom datasets and species-agnostic annotation.
Methodology:
Implemented as a Python module that applies a reduced amino acid alphabet and integrates multiple HMM alignments into a consensus model for sequence annotation.
Topics
Details
- License:
- GPL-3.0
- Cost:
- Free of charge
- Tool Type:
- command-line tool
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- Python
- Added:
- 2/24/2022
- Last Updated:
- 2/24/2022
Operations
Data Inputs & Outputs
Sequence alignment conversion
Inputs
Outputs
Publications
Dorey-Robinson D, Maccari G, Borne R, Hammond JA. IgMAT: immunoglobulin sequence multi-species annotation tool for any species including those with incomplete antibody annotation or unusual characteristics. Unknown Journal. 2021. doi:10.1101/2021.09.22.461368.